Marc Ullman was quoted in a NutraIngredients-USA article, “Indictment handed down in Florida over sale of SARMs, steroids.” Six people and two companies were charged by federal prosecutors for allegedly selling drugs unapproved by the FDA as supplements. “Some of these people seem to think, ‘What’s the worst that can happen to me? A warning letter? …
Read More

Robert Iseman penned a Thought Leaders Corner column for Population Health News in which he makes suggestions regarding how healthcare organizations can manage the social determinants of health (SDOH) within their patient population. Robert noted, among other things, “It is easy for a health system to get carried away in the world of SDOH. It is …
Read More

Cassandra Rivais was selected to serve as a reviewer for the abstracts of American Society of Bioethics and Humanities’ annual conference.  The organization hand-picks who will serve as reviewers, and reviewers get special recognition during the conference program. …
Read More

On April 2, Marc Ullman, along with the EAS Consulting Group, will conduct a Dietary Supplement GMP Seminar to help firms prepare for increased FDA enforcement. Given by former FDA compliance officials and industry experts, this intensive training program will provide all the information needed to comply with the rules, covering the responsibilities of domestic and …
Read More

Long Island Business News hosted a roundtable discussion on the current state of the healthcare industry. Rivkin partners Robert Iseman and Benjamin Malerba were joined by Dr. Zeyad Baker, ProHEALTH Care Associates’ president and CEO; Jeffrey Kraut, executive vice president of strategy and analytics at Northwell Health; and Dr. Simon Prince, president and CEO of …
Read More

Marc Ullman was quoted in a Nutraingredients-USA article, “Gottlieb: FDA plans meeting in April on new CBD regulations.” FDA Commissioner Scott Gottlieb said the agency is planning a public meeting in April to initiate a rule making procedure on CBD. Click here to read the article. …
Read More

Eric Fader weighed in on an article in Healthcare Risk Management discussing the HHS Office for Civil Rights’ request for information (RFI). The RFI seeks comment on how the HIPAA Privacy Rule might be changed to allow for better coordination of care among providers. Eric noted that the Treatment, Payment, and Healthcare Operations exception to …
Read More

Marc Ullman was quoted in a NutraIngredients-USA article, “Stakeholders cautiously optimistic on Gottlieb’s proposal for info protection in NDI filings.” The comments made by the FDA Commissioner Scott Gottlieb, MD, on the NDI’s issue have made dietary supplement industry stakeholders sit up and take notice. “I’m encouraged just in that it is good to hear …
Read More

Karen E. Sosler, with the assistance of Stacey L. Goldstein and Cassandra J. Rivais, successfully merged i) Seton Health Foundation, Inc. into The Northeast Health Foundation, Inc., ii) Seton Auxiliary, Inc. into Seton Health System, Inc., and iii) Seton Health System, Inc. into Samaritan Hospital of Troy, New York  in an effort to create administrative …
Read More

Robert H. Iseman was featured prominently in Relias Media’s Healthcare Risk Management newsletter. In the article, “FTC Investigations Could Bring Unwanted Scrutiny to Hospitals,” Bob notes that hospitals and health systems with “must have” status face substantial antitrust risk. He also suggests that the increased focus on anti-steering provisions is due to two pending cases. …
Read More